Publication Cover
Acta Clinica Belgica
International Journal of Clinical and Laboratory Medicine
Volume 29, 1974 - Issue 6
2
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Maladies Auto-Immunitaires Et Traitement Immunodepresseur II. Indications Actuelles En Clinique

Pages 413-423 | Published online: 21 May 2016

References

  • (Hépatologie) Cook, C.G., Mulligan, R. & Sherlock, S. – Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Q. J. Med., 40, 159, 1971.
  • Javitt, N.B. – Chronic active hepatitis. Am. J. Med, 55, 733, 1973.
  • Roef, R.S. – Chronic inflammatory liver disease : reexamination in perspective. Gastroenterol., 66, 465, 1974.
  • Meyer Zum Buschenfelde, K.H., Friedrichs, M. & Forster, E. – Immunosuppressive therapy in chronic inflammatory liver diseases. Immunosuppressive therapy, 69. Ed. P.A. Miescher 1973, Schwabe 2 Co. Basel/Stuttgart
  • Murray-Lyon, I.A., Stern, R.B. & William, R. – Controlled trial of Prednisone and Azathioprine in active chronic hepatitis. Lancet I, 735, 1973.
  • Soloway, R.D., Summerskill, W.H.J., Bag-Genstoss, A.H., Schoenfield, L.J. & Stubbs, B.L. – Clinical, biochemical and histological remission of serum chonic active liver disease : a controlled study of treatment and early prognosis. Gastroenterology, 63, 820, 1972.
  • Summerskill, W.H.J. – Chronic active liver disease reexamined : a pragnosis hopeful. Gastroenterol, 66, 450, 1974.
  • (Purpuras thrombopéniques idiopathiques) Muller-Ehberhardt, C. & Kretschmer, V. – Immunosuppresive therapy in blood diseases, p. 85 in Immunosuppressive therapy, 1973. Ed. P.A. Miescher, Schwabe Co, Basel, Stuttgart.
  • Finch, S.C., Castro, D., Cooper, M., Covey, W., Erichs, R. & Mc Phadran, P. – Immunosuppressive therapy of chronic idiopathic thrombocytopenic purpura. Ann. J. Med., 56, 4, 1974.
  • (Anemies hemolytiques autoimmunes)Muller-Ehberhardt, C. & Kretschmer-V. – Immunosuppressive therapy in blood diseases, p-85 in Immunosuppressive therapy, 1973. Ed. Miescher, P.A. Schabe Co, Basel, Stuttgart.
  • Habibi, B., Homberg, J.C., Schaison, G. & Salmonn, C. : Autoimmune hemolytic anemia >n children. Am. J. Med, 56, 61, 1974.
  • (Maladies inflammatoires de I’intestin) Asquith, P., Kraft, S.C. & Rothberg. R.M. – In vitro lymphocyte response to non-specific mitogens in inflammatory bowel disease. Gut, 13, 318, 1972.
  • Brown, S.M., Tayb, R.N. & Present. D.N. – Short term lymphocyte cultures in regional enteritis. Lancet, I, 1112, 1970.
  • Papp, J.P., Watson, D. & Bull, F. – Azathioprine treatment in Crohn's disease. Am. J. Gastroent., 136, 1971.
  • Fielding, J.F., Prior, P., Waterhouse, J.A & Cooke, W.T. – Malignancy in Crohn's disease. Scand. J. Gastroent., 7, 3, 1972.
  • Brooke, B.N., Javett, S.L. & Davison, O.W. – Further experiences with azathioprine for Crohn's disease. Lancet, II, 1050, 1970.
  • Klein, M. & Binder, H.J. – Treatment of Crohn's disease with azathioprine : a controlled evaluation-Gastroent., 66, 916, 1974.
  • Willoubhby, J.M.T., Kumar, P.J. & Beckett, J. – Controlled trials of azathioprine in Crohn disease. Lancet II, 944, 1971.
  • Steinberg, A.D. – Cytotoxic drugs in non malignant diseases. An. Int. Med., 76, 619, 1972.
  • (Néphrologie) Watson, D.W. & Johnson, A.G. – The clinical use of immunosuppressants. Med. Clin. N. Amer., 53, 1225,1969.
  • Herdman, R.C., Michael, A.F. & Good, R.A. – Proc. 4th Int. Congr. Nephrology, Stockholm Vol. 3, 62, 1969. Karger, Basel 1970.
  • Medical Research Council Working Party on trolled trial of azathioprine and prednisone in chro renal disease. Brit. Med. J., II, 239, 1971.
  • Soothill, J.F., Barratt, T.M. & McLaine P.N. – Controlled studies of the treatment of steroid resistant and steroid sensitive relapsing nephrotic syndrome. Proc. IVth Int. Congr. Nephrology, Stockholm, Vol. 3, 88, 1969. Karger & Co, Basel 1970.
  • Drummond, K.N. – Treatment with cyclophospamide of resistant and relapsing nephrosis in childhood. Proc. 4th Int. Congr. Nephrology, Stockholm, Vo1. 3, 72, 1969. Karger, Basel 1970.
  • Lange, K. – Immunosuppressive treatment of the nephrotic syndrome and glomerulonephritis. Proc. 4th Int. Congr. Nephrology, Stockholm, 102, 1969 Karger, Basel 1970.
  • Varese, L.A. – Terapia con immunosuppressari nellc sindromi nefrosiche primitive in et à pediatrica. Minerva paediat., 23, 262, 1971.
  • (P.C.E.) Ansell, B. & Bywaters, E. – Chlorambucil therapy in Still's disease with amyloïdosis. Symposium on Immunosuppressive treatment of systemic disease of the connective tissue. Belgrade, 6th and 7th October 1972.
  • Arsov, D. & Guceva, B. – Immunosuppressive treatment in rheumatology. Symposium on Immunosuppressive treatment of systemic disease of the connective tissue. Belgrade, 6th and 7th October 1972.
  • Belchert, A. – Azathioprine and cyclophosphamide as immunosuppresive agents : a confrontation. Rheumatoïd Arthritis, 689, Colloquia Geigy, 1971. Edited by Muller, W„ Hawerth, H. and Kuhr, E. Academic Press, London.
  • Camus, J.P. – Traitement de la polyarthrite rhumatoïde par la D-Pcnicillamine. La Thérapeutique, 312, 1972.
  • Cayla, J. & Rondier, J. – A propos du traitement de 67 polyarthrites rhumatoïdes par le chlorambucil. Revue Rhum. Mai. ostéo-artic, 38, 765, 1971.
  • Christian, Ch. – Rheumatoïd arthritis. Immuno logical diseases. Max Samter Editor Second edition, P- 1014, 1971. Little, Brown and Company, Bosjon.
  • Cooperating clinics committee of the american rheumatism association : A controlled trial of cyclophosphamide in rheumatoïd arthritis. N. Engl. J. Med., 283, 883, 1970.
  • Crouzet, J. – Traitement pratique de la polyar-thrite rhumatoïde. La Revue du Practicien, 42, 3705, 1973.
  • Currey, H. – Experience with immunosuppressive drugs in rheumatoid arthritis and in rodents. Sym-posium on Immunosuppressive treatment of systemic disease of the connective tissue, Belgrade, 6th and 7th October 1972.
  • Curtis, J., Sharp, J., Lidsky, M. & Hersh, E.-Immune response of patients with rheumatoid arthritis during cuclo-phosphamide treatment. Arthritis Rheum, 16, 1, 1973.
  • Denman, E., Denman, A., Greenwood, B., Gall, D. & Heath, R. – Azathioprine and chlorambucil in Arthritis rheumatoid. Ann. Rheum. Disease, 29, 220, 1970.
  • Delbarre, P. & Kahan, A. – Effect and mode of action of chlorambucil in rheumatoid arthritis. "Rheumatoid arthritis" Colloquia Geigy, edited by Muller, W., Harwert, H. & Kuhr, F., Academic Press London, p. 701, 1971.
  • Golding, J., Wilson, J. & Day, A. – Observations on the treatment of rheumatoid disease with penicillamine. Post gr. med. J., 46, 599, 1970.
  • Hurd, E. & Ziff, M. – Parameters of improvment in patients with rheumatoid arthritis treated with cyclophosphamide. Arthritis Rheum., 17, 1, 1974.
  • Huskisson, E. & Dudley, H. – Penicillamine in the treatment of rheumatoid arthritis. Ann. Rheum. dis., 31, 402, 1972.
  • Jaffe, I. – The treatment of rheumatoid arthritis and necrotizing vasculitis with penicillamine. Arthritis Rheum., 13, 436, 1970.
  • Jesseren, H. – Clinical experience of immuno-suppressive treatment in rheumatoid arthritis. Rheumatoid arthritis, 699, Colloquia Geigy, 1971. Edited by Muller, W., Haverthe, H. & Kuhr, F. Academic Press, London.
  • Krstic, S., Misatovic, M„ Ivkovic, L., Ciko, Z. & Micie, R. – Observation on the cytostatic treatment in selected cases with systemic disease of the connective tissue. Symposium on Immunosuppressive treatment of systemic disease of the connective tissue. Belgrade, 6th and 7th October 1972.
  • Lejeune, E. – La thérapeutique immunosuppressive de la polyarthrite rhumatoi'de. Le Contours Med., 95, 17, 1973.
  • Levy, J., Paulus, H. & Barnett, E. – A double blind, controlled evaluation of azathioprine treatment in rheumatoid arthritis and psoriasitic arthritis. Arthritis Rheum., 15, 116, 1972.
  • Lidsky, M., Sharp, J. & Billings, S. – Double blind study of cyclophosphamide in rheumatoid arthritis. Arthritis Rheum., 16, 2, 1973.
  • Lievre, J.A. &. Camus, J.P. – Traitement de la polyarthrite rhumatoïde commune par la D-Penicilla-mine. Ann Med. Int., 122, 555, 1971.
  • Lorenzen, I. & Videbek, A. – Treatment of collagen disease with cytostatics. Lancet I, 558, 1965.
  • Mason, M., Currey, J. & Barnes, C. -Rheumatoid arthritis. Brit. Med. J., 1, 420, 1969.
  • Mason, M, Harris, J., Brownsohn, A., Currey, H. & Dixon, A. – Azathioprine, cyclophosphamide and gold in the treatment of rhumatoid arthritis: A clinical trial. Arthritis Rheum., 15, 122, 1972.
  • Controlled trial of D-Penicillamine in severe rheu-matoid arthritis. Multicent re trial group. Lancet I, 275,1971.
  • Mjolnlnerod, O. & Dommeruds, S. – Congenital connective tissue defect probably du to D-Penicillami-ne treatment in pregnancy. Lancet I, 673, 1971.
  • Paolaggi, J.B. – Polyarthrite rhumatoïde de l'adulte. Rev. Prat., 23, 5133, 1973.
  • Sakovljev D. & Cvetkovic P. – Immunosuppressive treatment of juvenile rheumatoid arthritis. Symposium on Immunosuppressive treatment of systemic disease of the connective tissue. Belgrade, 6th and 7th October 1972.
  • Smyth, C. – Cyclophosphamide alone and combined with prednisone in the treatment of rheumatoid arthritis. Arthritis Rheum., 15, 38, 1972 (abstract 121).
  • Stoeber, E. & Kolle, G. – Long term immunosuppressive treatment of visceral forms of rheumatoid arthritis in children. Symposium on Immunosuppressive treatment of systemic disease of the connective tissue. Belgrade, 6th and 7th October 1972.
  • Stojanovic, I., Budimir, M., Nikolic, J. & Lukacevil, D. – Comparaison of the effect of treatment of rheumatoid arthritis with chlorambucil and cyclophosphamide. Symposium on Immunosuppressive treatment of systemic disease of the connective tissue. Belgrade, 6th and 7th October 1972.
  • Strong, J., Bartholomew H. & Smyth, C. – Immunoresponsiveness of patients with rheumatoid arthritis receiving cyclophosphamide or gold salts. Ann. Rheum, dis., 32, 233, 1973.
  • Vargazen, B. – Imuran in the treatment of inflammatory rheumatism. Symposium on Immuno-suppressive treatment of systemic disease of the con-nective tissue. Belgrade, 6 th and 7 th October 1972.
  • Urowitz, M., Gordon, D. & Smythe, H. – Azathioprine treatment of rheumatoid arthritis-odouble-blind, crossover study. Arthritis Rheum., 14, 419, 1971.
  • Zuckner, J., Ramsey, H., Dorner, W. & Gantner, G. – D-Penicillamine in rheumatoid arthritis. Arthritis Rheum., 13, 131, 1970.
  • (Lupus erythemateux diffus) Amor, B., Kalan, A., Brouilhet, H. & Delbarre, F. – The effects of immunosuppressive drugs in systemic lupus erythematosus. Proc. 8th Europ. Congress Allergology, Marseille, octobre 1971.
  • Arsov, D. & Boginja, L. – Immunosuppressive treatment in Rheumatology. Symposium on Immunosuppressive treatment of systemic disease of the connective tissue, Belgrade 6th and 7th October 1972
  • Corley, C, Lessner, H. & Larsen, W. – Azathioprin therapy of autoimmune disease. Am. J. Med, 41, 404, 1966.
  • Donadio, J.V. & Waganer, R.D. – Treatment of patients with lupus nephritis with prednisone and combined prednisone-azathioprine. Ann. Intern. Med., 76, 873, 1972.
  • Fries, J., Sharp, G., Mcdevitt, H. & Holman, H. – Cyclophosphamide therapy in S.L.E. and polymyositis. Arthritis and Rheum, 16, 154, 1973.
  • Halsted, H. – Systemic lupus erythematosus. Immunological diseases. Second edition, Max Samter Editor, p. 995, 1971 Little Brown and Company -Boston -
  • Kzstic, S., Mijatovic, M., Ivkovic, L., Ciko, Z. & Micie, R. – Observation on the cytostatic treatment in selected cases with systemic diseases of the connective tissue. Symposium on immuno-suppressive treatment of systemic diseases of the connective tissue. Belgrade, 6th and 7th October 1972.
  • Lagner, G. – Le malade sous immuno-dépresseur. Concours médical, 95, 17, 1973.
  • Nikolic, J., Budimir, M., Stosanovic, I. & Berovic, Z. – Several years of experience with Imuran in the treatment of systemic lupus erythematosus. Symposium on Immunosuppressive treatment of systemic disease of the connective tissue. Belgrade 6th and 7th October 1972.
  • Snaith, M., Holt, J., Oliver, D., Dunnill, M-. Halley, W. & Stephenson, A. – Treatment of patients with systemic L.E. including nephritis with chlorambucil. Brit. Med. J., 2, 197, 1973.
  • Sharon, E., Jones, J., Dia-Mond, H. & Kaplan, D. – Pregnancy and azathioprine in systemic lupus erythematosus. Am. J. Obst. Gynec, 118, 25, 1974.
  • Steinberg, A.D., Salisburz, K.W. & Hadler. N. – Controlled trial of azathioprine, cyclophosphamide or placebo in lupus nephritis. Arthritis and Rheum, 15, 456, 1972.
  • Steinberg, A.D., Kaltreider, M.B. & Staples, P.- Cyclophosphamide in lupus nephritis : a controlled trial. Ann. Inter. Med, 75, 165, 1971.
  • Szteinbock, M., Stewart, A., Diamond, H. & Kaplan, D. – Azathioprine in the treatment of systemic lupus – A controlled study. Arthritis an" Rheum, 14, 639, 1971.
  • Thivolet, J. & Perrot, H. – Les médications cytotoxiques dites immunosuppressives dans le lupus érythémateux dissémine et la sclérodermic Bull. Soc-Fr. Derm. Syph., 11,412, 1970.
  • Vargazen, B. – Imuran in the treatment of in-flammatory rheumatism. Symposium on immunosuppressive treatment of systemic disease of th connective tissue. Belgrade 6th and 7th October 1972.
  • Azathioprine in systemic lupus erythematosus. Editorial Lancet, 704, 1973.
  • (Sclérodermic, dermatomyosites et polymyosites) Arsov, D. & Guceva, B. – Immunosuppressive treatment in rheumatology. Symposium on Immun suppressive treatment of systemíc disease of the connective tissue. Belgrade, 6th and 7th October 1972.
  • Benson, M., Aldo, M. & Washington, D- – Azathioprine therapy in polymyositis. Arch. Intern. Med., 132. 547, 1973.
  • Czerniclewski, A. & Olszewska, Z. – Lecture given during Dermatological Congress, Opatya -Yugoslavia – 1972
  • P- Miescher, Cerebtzof F. & Lambert, P. – Immunosuppressive therapy of Dermatomyositis. Immunosuppressive therapy, 41. Proc. Int. Wiesbaden Symposium 1972. Sehwabc and Co. Basel/Stuggart.
  • Pearson, L. – Polymyositis and Dermatomyositis. Immunological diseases, second edition, Max Samter Editor, p. 1039, 1971 Little, Brown and Compagny, Boston.
  • W. Stogmann – Erjahrungen in der Behendlung der dermatomyositis mit immunosuppressive. Pediatric und Padologie, 7, 305, 1972.
  • Thivolet, J. & Perrot, H. – Les médications cytotoxiques dites immunosuppressives dans le lupus érythémateux aigu disséminé ct la sclérodermie. Bull. Soc. Fr. Derm. Syph., 11, 412, 1970.
  • Vargazon, B. – Imuran in the treatment of inflammatory rheumatism. Symposium on Immunosuppressive treatment of systemic disease of the connective tissue. Belgrade, 6th and 7th October 1972.
  • (La périarterite noueuse, artérite a cellules géantes et maladie de Wegener)Dale, D. Fauli, A. & Wolff, S. – The effect of cyclophosphamide on leukocyte kinetics and susceptibility to infection in patients with Wegener's granulomatosis. Arthritis and Rheum, 16, 5, 1973
  • Corley, C. & Lessner, H. – Azathioprine therapy in "autoimmune diseases" Am. J. Med., 41, 404, 1966.
  • Froment, P. & Sheps, S. – Long term follow-up study of periarteritis nodosa. Am. J. Med., 43, 8, 1967.
  • Krstic, S., Mijatovic, M„ Ivkovic, L., Ciko, z- & Micif, H. – Observation on the cytostatic treatment in selected cases with systemic diseases of the connective tissue. Symposium on Immunosup pressive treatment of systemic disease of the connecti ve tissue. Belgrade 6th and 7th October 1972.
  • Lorenzen, I. & Videbek, A. – Treatment of co'lagcn diseases with cytostatics. Lancet I, 558, 1965.
  • Melam, H. & Patterson, R. – Periarteritis nodosa : A remission achieved with combined prednisone and azathioprine therapy. Am. J. Dis. Child, 121, 424, 1971.
  • Miescher, P., Gerebtzoll, A. & Lambert, P. – Immunosuppressive treatment of polyarteritis nodosa. Immunosuppressive therapy, Proceedings of the International Wiesbaden Symposium 1972, 40.
  • (Syndrome de Sjögren) Arsov, D. & Guceva, B. – Immunosuppressive treatment in rheumatology. Symposium on Immunosuppressive treatment of systemic disease of the connective tissue. Belgrade, 6th and 7th October 1972.
  • Bloch, K. & Myers, A. – Sjögren's syndrome. Immunological disease, second edition, Max SAMTER, Editor, p. 1172, 1971 Little Brown and Company.
  • Pirsis, W. & Donath, K. – Zur ultrastruktur der parotis beim Sjögren syndrom vor und nach immuno-suppressiver therapie. Arch. Klin. Exp., 201, 309, 1972.
  • (Maladies ncurologiques) Colin-Jones, D.G. & Heathfield, K. – 6 mercaptopurine in polyradiculoneuropathy. Lancet, 739, 1965.
  • Palmer, K.N.V. - Polyradiculoneuropathy treated with cytotoxic drugs. Lancet, 265, 1966.
  • Palmer, K.N.V. – Polyradiculoneuropathy treated with 6-mercaptopurine. Lancet, 733, 1965.
  • Gamstorp, I., Aronsson, S. & Lindquist, B. – Mercaptopurine in polyradiculoneuropathy. Lancet, 99, 1966.
  • Heathfield, K. & Dallos, V. – Treatment of polyneuropathy with azathioprine. Lancet, 1031, 1970.
  • Delwaide, P.J. – Premiers essais de traitement de la myasthenic par azathioprine. Acta Neur. Belg., 701, 1967.
  • Mertens, A.G. – The treatment of severe myasthenia gravis with immunosuppressive agents. Europ. NeuroL, 2, 321, 1969.
  • Brendel, W., Seifert, J. & Lob, G. – Effect of "Maximum immune suppression" with thoracic duct drainage, ALC azathioprine and cortisone in some neurological disorders. Proc. R. Soc. Med, 65, 531, 1972.
  • Siberberg. D., Lisak, R. & Zweiman, B. – Multiple sclerosis innaffected by azathioprine in pilot Study. Arch Neurol, 28, 210, 1973.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.